Yükleniyor... / Loading...
Encodes chromatin remodeling protein. Mutations cause alpha-thalassemia/intellectual disability syndrome.
Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.
ATRX No associated disease records found for this gene.